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Introduction to CTSAs and ICTS 
Kristi L. Holmes, PhD 
Hold on to your hats. 
Objectives 
1. Understand the activities, tools, and logistics for 
assessing research productivity 
2. Have a better understanding of evaluation activities 
for groups or individuals anywhere along the 
academic career trajectory, from scholars to tenured 
faculty 
3. Understand data sources and how they can be 
leveraged in assessment of impact and research 
discovery 
4. Understand how to tell the story of research impact 
and strategies to enhance research impact 
Translational Research  
Working Together, Sharing a Vision 
The CTSA consortium has 
five Strategic Goals: 
• National Clinical and Translational 
Research Capability 
• The Training and Career 
Development of Clinical and 
Translational Scientists 
• Consortium-Wide Collaborations 
• The Health of our Communities 
and the Nation 
• T1 Translational Research 
 
The CTSA Consortium aims to 
improve human health by 
transforming the research and 
training environment to enhance 
the efficiency and quality of 
clinical and translational research. 
 
From https://www.ctsacentral.org/about-us/ctsa 
ICTS Strategic Goals 
• Transform our research support 
infrastructure to foster multidisciplinary 
clinical & translational research 
 • Expand & enhance clinical & 
translational research education 
• Promote & facilitate regional & 
national partnerships 
 
ICTS Tracking & Evaluation Goals 
• Track and monitor the integration of services and 
activities of the overall ICTS, and ICTS cores. (ICTS Goal 1) 
• Assess the growth in scientific capacity resulting from 
the ICTS education and training activities (ICTS Goal 1) 
• Assess the growth in scientific and institutional 
collaborations and communication as a function of ICTS 
activities. (ICTS Goal 3) 
• Evaluate the impact of the ICTS on scientific and 
scholarly work (ICTS Goal 2) 
An interdisciplinary approach 
to tracking and evaluation 
• AC: ICTS Administrative Core 
• Becker: Bernard Becker 
Medical Library 
• CPHSS: Center for Public 
Health Systems Science 
• CRTC: Clinical Research 
Training Center 
 
T&E Reports to ICTS Governance 
• Accountable to ICTS Director  
• Periodic reports to all levels of governance as 
well as NIH/NCATS 
 
What to count? What matters? 
IOM CTSA Report released 6/25/13  
Areas of emphasis: 
• Formalize and standardize evaluation processes for 
individual CTSAs and CTSA Program 
• Advance innovation in education and training programs 
• Ensure community engagement in all phases of research 
• Strengthen clinical and translational research relevant to 
child health 
• Further engage strategic partnerships with a range of 
public/private partners (patients groups, industry, 
foundations, NIH Institutes, etc.) 
• Build on the strengths of individual CTSAs across the 
spectrum of clinical/translational research 
 
http://http://goo.gl/zykHVQ  
What to count? What matters? 
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15 Consortium Wide Metrics 
Data Collection & Analysis 
 
• Time from IRB submission to approval – 
IOM studies  
• Studies meeting accrual goals  
• Time from notice of grant award to 
study opening (e.g., investigator 
initiated studies)  
• Number of technology transfer 
products  
• Volume of investigators who used 
services  
• Volume of types of services used  
• Time to publication  
• ROI of pilot and KL2 scholars  






• Influence of research publication 
(e.g., observed/expected citations)  
• Researcher collaboration (e.g., team 
science; collaboration index)  
• Career development  
• Career trajectory (e.g., K-R transition)  
• Institutional collaboration (public-
private; cross-institutional; 
community)  
• Satisfaction/needs assessment  
The workshop 
Workshop Outline 
• Areas of Focus 
– Scientific Productivity 
– Scientific Collaboration 
– Integration of ICTS Operations 
– Dissemination 
– Impact 
• Supporting dissemination and impact  
• Open Discussion 
Questions? 
Scientific Productivity 
Cathy C. Sarli, MLS, AHIP 
Defined as scholarly, peer-reviewed articles authored by ICTS members. 
Scientific Productivity 
• Data 
– Publication and citation data 
• Databases  
• Self-reported 
 
• Analysis  
– Bibliometrics 




– Scientific visibility of publications 
– Change in collaboration or authorship patterns 
 
 
What is Publication Data? 
Source  
Document Type 















Index  Keywords 
Date 
Funding Agency Names 





• Annual publication data capture for ICTS members from Scopus 
via csv. file. 
 Article 
 Conference Paper 
 Review 
 Short Survey 
• Each ICTS member has unique ID. 
• ICTS members divided into cohorts to track progress over time. 
• All ICTS members, former and current, included in the annual 
publication capture.  
• Publication files sent to CPHSS for clean-up  
 
Publication Data: Annual Capture 
Publication Data: Challenges 
Challenges with Capture: 
• Tracking new and former ICTS members. 
• Author disambiguation: 
 Splitting 
 Lumping 
• Did we capture all publications?  
 Self-reporting and serendipity 
 Challenges with Clean-up: 




 Scopus link to record 
• Final manual clean-up required. 
 
Citation Data: Annual Capture 
and Challenges 
Process: 
• Top 50 cited articles from Scopus 
compared to Web of Science 
citation data on annual basis.  
• Web of Science citation data 
analyzed using Essential Science 
Indicators on annual basis. 
- Hot Papers 
- Highly Cited Papers 
- Core Papers (Research Fronts) 
• Citation data from Scopus and Web 





• Manual process 
• Are citations indicative of 





A citation is a reference 
to a specific publication. 
 
Publication/Citation Data: 
Five ICTS Examples  
 
• Benchmarking 
• Scientific Visibility and Influence 
• Authorship Patterns 
• Timeframe from Funding to Publication 
• Timeframe from Publication to Outcomes 
 
Why?  
Narratives of “success stories” based on ICTS-supported research. 










10. Associated   










10. Risk  
Publication Data Elements 2008 2012 
Publications in Scopus 2,365 3,160 
States represented  49 49 
Articles  1,968 2,679 
Reviews  288 477 
Unique journal titles 938 1,244 
2012 Top Eight Journals  
1. PLoS ONE 




6. J. of Virology   
7. American J. of Ob. and Gynecology 
8. Neurology and J. of Neurology (tied) 
 
2008 Top Eight Journals  
1. J. of Biological Chemistry 
2. J. of Pediatrics 
3. American J. of Ob. and Gynecology 
4. Blood 
5. PNAS 
6. J. of Immunology 
7. Inf. Control and Hosp. Epidemiology 
8. J. of Virology   
 
Publication Activity:  2008 and 2012 
Scientific Visibility and Influence: Citations and ICTS Members (2010-2012)  
Examples of Funding Agencies Represented 
by 2012 Citations: 
• Association  Francaise Contre les Myopathies 
• Chinese Academy of Sciences 
• Deutsche Forschungsgemeinschaft Germany 
• Fundacion Alfonso Martin Escudero 
• German National Genome Network 
• Japanese Science and Technology Agency 
• Ministero Della Salute 
• Netherlands Heart Foundation 
• State of Bavaria 
• Swedish Research Council 
• Swiss National Science Foundation 
• Wellcome Trust 
 
 
The top 50 cited-by publications authored by ICTS 
members in 2012 had at least 12 citations per Web of 
Science as of May 2013 with an average of 47 citations 
per paper. 11 publications had more than 62 citations 
each with the highest citation count being 111. 34 
publications had citation rates between 23 and 62. 
 
According to Essential Science Indicators, as of May 
2013: 
• The average citation rate for a paper published in 
2012 for all fields is .75.  
 
• A paper published in 2012 that garners eight 
citations falls in the top 1% of cited papers for all 
fields.   
 
• A paper published in 2012 that garners 23 citations 
falls in the top .10% of cited papers for all fields. 
 
• A paper published in 2012 that garners 60 citations 
falls in the top .01% of cited papers for all fields. 




2010 2,265 4,453 
2011 2,483 3,782 
2012 3,160 9,132 






2010-2011 44 29 
2011-2012 60 45 
Examples of Languages 












Authorship Patterns: Inter-CTSA Collaboration for 2012 
In 2012, ICTS members co-authored publications with 






Awarded JiT  




Imaging (DTI) as an 




October 2012  
PMID:  22968768 
FINDINGS: 
Study results confirmed that 
cerebrospinal fluid abnormalities and 
magnetic resonance imaging (MRI) 
can assist in distinguishing CJD 
patients from non-prion RPD 
patients, calling for future 
longitudinal studies to evaluate 
pathological changes seen in CJD 
patients. 
Beau M. Ances, MD, PhD, MSc 
Associate Professor of Neurology at Washington University in St. Louis 
Journal Article Published 
Sept 2012 as Early E-Pub 
Creutzfeldt-Jakob Disease (CJD) is a rapidly progressive 
neurodegenerative disease  (RPD) with diagnosis often made at 
autopsy. The goal of this work is to identify early changes in the 
brain structure due to CJD. This may allow for early intervention. 




PMID:  22968768 
Beau M. Ances, MD, PhD, MSc 
Associate Professor of Neurology at Washington University in St. Louis 
Journal Article Published 
Sept 2012 as Early E-Pub 
Time From Publication to Outcomes with Promise for Clinical Synthesis 
INITIAL OUTCOMES: 
• Increase in knowledge of CJD and RPD. 
 
• Creation of pilot data to support justification for future funding 
applications. 
 
• New u derstanding of characterizations of patients with RPD. 
 
• Identification of clinical and diagnostic tests to distinguish CJD from 
RPD, i.e., MRI and lumbar puncture. 
 
• Identification of new research directions to pursue, i.e., longitudinal 
studies of pathological changes in CJD. 
 
• Enhanced awareness of RPD and CJD via symposium. 
 
• Recognition from the CJD Foundation as source of knowledge and 
assistance for patients and families. 
 
• Increase in new referrals of patients as a result of the symposium.  
Recap 
Uses of Publication and Citation Data: 
 
• “Snapshot in Time” or Benchmarking. 
• Track the 15 Consortium Metrics. 
• Identify authorship/collaboration patterns. 
• Identify publication practices. 
• Identify and highlight promising publications, investigators or studies. 
• Grant reporting and renewal purposes. 











• What stories to tell of ICTS success? 







Bobbi Carothers, PhD 
Defined as activities that stem from ICTS scientific productivity. 
Why Care About Collaboration? 
• ICTS Aim 3: Assess the growth in scientific and 
institutional collaborations and communication 
as a function of ICTS activities 
• Medical science is a collaborative process 
• Necessary for translation from bench to 










• Plan to work together 
• Work together 
• Disseminate results of the work 
Collaboration Networks 
• Data: Links between investigators 
– Grant Submissions 
– Research Collaborations 
– Publication Co-authorships 
• Analysis: Social Network Analysis 
– Number of collaborations 
– Cross-discipline mix 
• Impact: Change over time 
DATA 
Collection 
Relationship Method Frequency 
Grant Submission Administrative Records Every 2 Years 
Research Collaboration Online Survey of 
Members (Qualtrics) 
Every 2 Years 
Publication Co-authorship Literature Review Annually 
Grant Submissions 























Participant Collaborator 1 Collaborator 2 Collaborator 3 
Jane Mark John Dana 















• Managed similarly to grant submissions 
Member ID Publication Title 
11 Cool cancer treatment report 
12 Cool cancer treatment report 
13 Cool cancer treatment report 
13 Nifty Alzheimer’s gene report 
14 Nifty Alzheimer’s gene report 







• Research Collaborations 
– 1400 members  too many for participants to hunt 
through a drop-down list in order to find collaborators   
– Participants write in the names of their collaborators 
• Many are not ICTS members 
• Creative spelling 
– Labor-intensive data cleaning 
• Publication Co-authorships 
– Variations in publication titles require cleaning 
– Not all publications appear with DOI or PubMed ID 
SOCIAL NETWORK ANALYSIS 
Visualizations 
Relationship Patterns 
Grant submission network (2007) 
• Before ICTS grant 
• Discipline denoted by color 
Out of 387 members 
# Submitted grants 236 





Publication Co-authorship Network 
(2007) 
Out of 387 members 
# Published 221 







Change over time 






Cross- to Within-discipline 
Collaboration Density Ratio 
2007 236 1.92 .216 
2010 257 4.81 .436 
2007 2010 
Publication Co-authorships, 2007 vs. 
2010 
Year # Members  
Average # 
Collaborators 
Cross- to Within-discipline 
Collaboration Density Ratio 
2007 221 2.02 .191 
2010 256 2.64 .230 
2007 2010 
Conclusions: Does ICTS Improve 
Collaboration? 
• Increase in number of people submitting grants 
and getting published 
• Increase in number of collaborators 
• Increase in cross-disciplinarity of collaborations 
• Pattern less strong for publications than grants 
likely due to lag time 
• Second research collaboration survey to occur in 
the fall 
RESOURCES 
What we used 
Where to get it 
Software 
• All are frequently updated 
Pajek UCINet R/Statnet 
Links 
• Pajek: http://pajek.imfm.si/doku.php?id=pajek 






 Integration of ICTS Operations 
Elizabeth Palombo, MEd 
Defined as integration of services and activities of ICTS within WU & resulting satisfaction by 
ICTS members, removal of barriers to conduct TR, more efficient TR activities, etc. 
ICTS Operations 
• Data:  
– Surveys 
– Service Use 
– Membership 
• Analysis: 
– Survey reports 
– Cross-disciplinary tables 
– Dashboards 
• Impact: 
– Enhance ICTS core services 
– Core/service funding allocation 
– Translational Research education 
– Reporting to ICTS Governance and NCATS/NIH 
Improve Member Research Experience 
and Reduce Barriers 
DATA: Member & Satisfaction Surveys 
• Methodical Plan 
– Avoid over-surveying 
– Helps with maintaining history and consistency 
• Survey Purposes 
– Satisfaction with cores and services 
– Marketing of ICTS, cores and services 
– Program evaluation 
– Core specific as requested 
• Beyond the ICTS 
– Siteman Cancer Center 




Standardized Core Questions 
1. Rate core satisfaction on: 
• Process to request services 
• Timeliness of services received 
• Quality of the services received 
2. Rate satisfaction with the core services  
3. Would you use the core services again? 
4. Comments 
DATA: ICTS Service Use 
• Purpose? Why is it important? 
• How is it reported? 
– Core Evaluation Coordinators 
– Service Tracker 
– Excel Spreadsheet 
• What is included? 
– Investigator Information 
– Service Details 
– Project Information 
DATA: Core Service User Departmental Distribution 
1 2 3 4 5 6
Saint Louis  Univers i ty (SLU) 1
Washington Univers i ty (WU)
Arts  & Sciences 2 4 4 4 6
Engineering 1 2 2 4 3
Anatomy & Neurobiology 1 1
Anesthes iology 1 3 4 3
Internal  Medicine 6 26 27 28 32 26
Neurologica l  Surgery 1 1 2 4
Neurology 7 18 21 20 21 23
Obstetrics  & Gynecology 2 2 2
Occupational  Therapy 1 1
Ophthalmology & Visua l  Sciences 1 1
Orthopaedic Surgery 3 6 3 5 4
Otolaryngology 1 1 2 4 1
Pediatrics 2 5 10 12 12 10
Phys ica l  Therapy 1 2 4 5 5 5
Psychiatry 2 7 11 10 8 7
Radiation Oncology 2 2 3 4 4 4
Radiology 9 13 18 20 23 25
Surgery 2 7 9 8 8 5
Total Unique Users Each Year   31 89 121 124 139 129
Year of Use
Institution/School/ DepartmentHuman Imaging Unit (HIU) 
Service Use  9/17/07-2/15/13 
220 Unique investigators used HIU 








Goldfarb School of Nursing (excluded from BJH total below) 7
Saint Louis University (SLU) (excluded from SLU total below) 4
Southern Illinois University Edwardsville (SIUE) 11
University Of Missouri - St. Louis (UMSL) 15
37
Barnes Jewish Hospital (BJH) 21
Community Organizations 6
St. Louis Children's Hospital (SLCH) 2
St. Louis College of Pharmacy (STLCOP) 36
Saint Louis University (SLU) 128
Partner Institutions Subtotal 230
Washington University (WU)
Danforth Campus
Arts & Sciences 23
Olin Business School 4
School of Engineering & Applied Science 14





Anatomy & Neurobiology 6
Biochemistry & Molecular Biophysics 8





Other School of Medicine Departments/Units
Administrative 6
Anesthesiology 31





Obstetrics & Gynecology 40
Occupational Therapy 21
Ophthalmology & Visual Sciences 27
Orthopaedic Surgery 48
Otolaryngology 31












School of Medicine Subtotal
ICTS Current Membership 
ANALYSIS: Survey Reports 
• Types of Reports 
– Executive Summary 
– Tailored to specific audience (membership, 
program directors) 
• Feedback Loop 
– Reporting to membership 
– Let them know we value their responses and time 
– Present examples of change because of responses  
ICTS Member Satisfaction Survey Results 
About the Survey:   
• Distributed  February 28 – April 5, 2013 
• Year 4 of ICTS/Siteman Cancer Center (SCC) collaborative effort  








• ICTS response rates:  43% in 2013,  54% in 2011,  38% in 2010,  28% in 2009 
– Names associated with completed surveys entered into random drawing 
– 6 prizes issued -  iPad (1)  &  B&N $20 Gift Card (5) 
 
• Core Director response/survey results to be discussed with director at their next 
scheduled meeting with Drs. Evanoff and Moley 
 
ICTS Core Service Satisfaction 










Core 1 97 171 4.16 4.17 
Core 2 36 33 4.33 4.33 
Core 3 18 20 3.81 4.25 
Core 4 27 29 4.54 4.26 
Core 5 27 8 4.90 4.56 
Core 6 129 62 4.40 4.28 
Core 7 43 46 3.89 3.92 





Number of Different Cores Used by Investigators as Reported in Survey 
# Different Cores Used 1 2 3 4 5 6 7 8 




3=Neither Satisfied nor Dissatisfied 
4=Somewhat Satisfied 
5=Very Satisfied 
Investigators Benefited from the ICTS Cores and Services 
Most Helpful Services Received from the ICTS Cores? 
(Check all that apply) 
15 Consortium Wide Metrics 
Data Collection & Analysis 
 
• Time from IRB submission to approval – 
IOM studies  
• Studies meeting accrual goals  
• Time from notice of grant award to 
study opening (e.g., investigator 
initiated studies)  
• Number of technology transfer 
products  
• Volume of investigators who used 
services  
• Volume of types of services used  
• Time to publication  
• ROI of pilot and KL2 scholars  





• Influence of research publication 
(e.g., observed/expected citations)  
• Researcher collaboration (e.g., team 
science; collaboration index)  
• Career development  
• Career trajectory (e.g., K-R transition)  
• Institutional collaboration (public-
private; cross-institutional; 
community)  
• Satisfaction/needs assessment  
https://www.ctsacentral.org/sites/default/files/documents/EvaluationF2F_Summary_20121018.pdf  
ANALYSIS: Dashboards 





Value of  
Information 
Level of  
Difficulty 












4 Number of technology transfer products 1, 3 Admin *** ++ 
5 Volume of investigators who used services 1 Service **** + 
6 Volume of types of services used 1 Service **** + 
7 Satisfaction/Needs assessment 1 Service *** + 
8 Time to publication (need to define time) Pubs * ++++ 
9 Influence of research publication (observed/expected citations) 3 Pubs **** ++ 
10 Researcher collaboration (team science; collaboration index) 3 Admin **** ++ 
11 ROI of pilot and KL2 scholars all Admin **** +++ 
12 Time from publication to a research synthesis Pubs *** ++++ 
13 Career development 2 Education *** ++ 
14 Career trajectory (includes K-R transition) 2 Education *** ++ 
15 Institutional collaboration (public-private; cross-institutional; community) 3 Admin *** ++++ 
Value of Information: **** = High Value   * = Low Value  Level of Difficulty: + = Low Difficulty   ++++ = High Difficulty 
T&E Effect on ICTS Operations 
• Enhance ICTS Services 
– Services added 
– Improved service delivery 
– Certain expertise added to meet needs 
• Core/Service Funding 
– Funding direction can change based on: 
• Feedback or service demands 
• Distribution of service users 
• Translational Research 
– Introducing a new way of thinking 
– Emphasis on moving research from one stage to next 
– Communicating that ICTS cores, staff and resources can 
help investigators go further with research 
Questions? 
Dissemination 
Kristi Holmes, PhD 
Defined as an active approach of spreading evidence-based interventions to the 
target audience via determined channels using planned strategies. 
Lomas J. Diffusion, dissemination, and implementation: who should do what? Ann N Y Acad Sci. 1993;703:226–235. 
MacLean DR. Positioning dissemination in public health policy. Can J Public Health. Nov–Dec 1996;87(Suppl 2):S40–S43. 
Some thoughts about dissemination 
What is dissemination? 
• Dissemination is an active approach of spreading evidence-
based interventions to the target audience via determined 
channels using planned strategies. 
• For the purpose of this workshop, we are also including the 
process of communicating results/findings to the general 
public or funding agencies or other stakeholders as 
DISSEMINATION. 
 
Brownson, Ross C, Colditz, Graham A, Proctor, Enola K. Dissemination and implementation research in health : translating science to practice. New York: Oxford University 
Press, 2012. Chapter 2. eBook. <http://www.oxfordscholarship.com/view/10.1093/acprof:oso/9780199751877.001.0001/acprof-9780199751877 >.  
Some thoughts about dissemination 
Dissemination Strategies for varied stakeholders 
• Dissemination strategies describe mechanisms and 
approaches that are used to communicate and spread 
information about interventions to targeted users. 
• Dissemination strategies are concerned with the packaging of 
the information about the intervention and the 
communication channels that are used to reach potential 
adopters and the target audience.  
• It is consistently stated in the literature that dissemination 
strategies are necessary but not sufficient to ensure 
widespread use of an intervention. 
Putting it into practice… 
Brownson, Ross C, Colditz, Graham A, Proctor, Enola K. Dissemination and implementation research in health : translating science to practice. New York: Oxford University 
Press, 2012. Chapter 2. eBook. <http://www.oxfordscholarship.com/view/10.1093/acprof:oso/9780199751877.001.0001/acprof-9780199751877 >.  
Some thoughts about dissemination 
Examples of dissemination 
– Passive dissemination strategies include mass mailings, 
publication of information including practice guidelines, 
and untargeted presentations to heterogeneous groups. 
– Active dissemination strategies include hands-on 
technical assistance, replication guides, point-of-decision 
prompts for use, and mass media campaigns. 
 
Motivations – Why disseminate? 
CRITICAL to communicate findings to various stakeholders – 
researchers, potential collaborators, partners, members of the 







Awarded JiT  




Imaging (DTI) as an 
Early Biomarker of 
Cruetzfelt-Jakob 
Disease (CJD) 
Hosted Symposium  
PMID:  22968768 
FINDINGS: 
Study results confirmed that 
cerebrospinal fluid abnormalities and 
magnetic resonance imaging (MRI) 
can assist in distinguishing CJD 
patients from non-prion RPD 
patients, calling for future 
longitudinal studies to evaluate 
pathological changes seen in CJD 
patients. 
Beau M. Ances, MD, PhD, MSc 
Associate Professor of Neurology at Washington University in St. Louis 
Journal Article 
Creutzfeldt-Jakob Disease (CJD) is a rapidly progressive neurodegenerative 
disease  (RPD) with diagnosis often made at autopsy. The goal of this work is to 
identify early changes in the brain structure due to CJD. This may allow for early 
intervention. 
Length of time from funding to publication 
Impact 
Kristi Holmes, PhD 
Defined as successful completion of research and communication of discoveries 
that leads to changes in knowledge and clinical practice. 
Impact?? HOW do you measure that? 
• Why measure? How to measure? 
• What things do people typically count? 




Wells R, Whitworth A. 2007. Assessing outcomes of 
health and medical research: do we measure what 
counts or count what we can measure? Australia and 
New Zealand Health Policy, 4:14 
“It is no longer enough to measure what we can – we need 
to measure what matters.” 
 
 
How do we measure what matters? 
A great resource: the RAND Report 
– Includes a detailed and critical review of a 
host of tested and documented assessment 
tools, which can be used for various 
purposes--whether for advocacy, 
accountability, analysis or internal allocation 
decision-making.  
– A related research brief is also available. 
• Measuring Research: A Guide to Research Evaluation 
Frameworks and Tools 
– AAMC commissioned a report from the RAND Corporation 
– Summarizes current conceptual models for how 
biomedical research translates into academic, health, 
social and economic impacts, and profiles 14 
robust  research evaluation initiatives already in use 
Tools 
• bibliometrics: a range of techniques for assessing 
quantity, dissemination and content of publications and 
patents; uses quantitative analysis to measure patterns 
of publication and citation, typically focusing on journal 
papers 
• surveys: provide a broad overview of the current 
status of a particular program or body of research; 
widely used in research evaluation to provide 
comparable data across a range of researchers and/or 
grants which are easy to analyze 
• logic models: graphic representation of the essential 
elements of a program or process; aims to encourage 
systematic thinking and guide planning, monitoring and 
evaluation 
• case studies: can be used in a variety of ways; flexible 
enough to capture a wide variety of impacts, including 
the unexpected, and can provide the full context around 
a piece of research, researcher or impact 
• economic analysis: comparative analysis of costs 
(inputs) and consequences (outputs); aims to assess 
whether benefits outweigh opportunity costs and 
whether efficiency is achieved; generally, there are three 
types of economic analysis: cost-benefit analysis (CBA), 
cost-effectiveness analysis (CEA) and cost-utility analysis 
(CUA) 
• peer review: review by peers, typically other 
academics in the same or a similar field, of outputs of 
research; rationale that subject experts are uniquely 
qualified to assess the quality of the work of others 
• data mining: allows access to and understanding of 
existing data sets; uses algorithms to find correlations 
and patterns and present them in a meaningful format, 
reducing complexity without losing information 
• interviews: used to obtain supplemental information 
on areas of interest, generally to access personal 
perspectives on a topic, or more detailed contextual 
information 
• data visualization: tool for data summarization, 
presenting large amounts of data in a visual format for 
human comprehension and interpretation 
• site visits: visit by evaluating committee to 
department and institution; generally consists of a series 
of meetings over one or more days with a range of 
stakeholders 
• document review: review of existing documentation 
and reports on a topic. 
 
What is it? 
When should it be used? 
How is it used? 
Frameworks 
• Canadian Academy of Health Science 
Payback Framework (Canada) 
• Excellence in Research for Australia 
(ERA) (Australia) 
• National Institute of Health Research 
Dashboard (England) 
• Research Excellence Framework (REF) 
(UK) 
• Productive Interactions (Netherlands 
and European Commission). 
• Science and Technology for America’s 
Reinvestment: Measuring the Effect 
of Research on Innovation, 
Competitiveness and Science (STAR 
METRICS) (US) 




Origin and rationale 
Scope 
Measurement 














 The Becker Model involves 
tracking research outputs 
that have been 
disseminated/diffused  
to locate indicators that 
 demonstrate evidence of  
research impact. 
Pathways 
Advancement of Knowledge 
Clinical Implementation 
Legislation and Policy Enactment  
Economic Benefit 
Community Benefit 
The Becker Model 
• Provides a supplement to publication analysis to provide a more robust 
and comprehensive perspective of biomedical research impact. 
– reporting templates, glossary of resources and terms, examples of relevant 
indicators of impact across the research process, readings, and a sample of a 
completed report   
• Straightforward framework for tracking diffusion of research outputs and 
activities to locate indicators that demonstrate evidence of biomedical 
research impact 
– individual, core, and institutional-level; modify for different disciplines 
• Guidance for quantifying and documenting research impact as well as 
resources for locating evidence of impact. 
 
• Strategies for enhancing the impact of research.  





Implementation of Becker Model 
• Case Study 




application of the 
Becker Model  
– Make it replicable and 
scalable at other sites 
– Develop an SOP or 
“product” for others to 
use.  
Target Sample Criteria:   
• Member of ICTS  
• Recipient of JiT or Pilot funding from 
ICTS or K12 support 
• ICTS member with high levels of 
collaboration (in renewal document) 
• A mix of ICTS members at various 
career stages including scholars 
• ICTS members (at least one bench, 
one clinical) and one project group 
such as a Core Facility that has 
received or is currently receiving 
funding from ICTS 
• Suggestions by T&E Team, and ICTS 
PIs and administrators 
Implementation of Becker Model 
Seminar Series for Investigators and Scholars and/or 
Recipients of ICTS Funding  
  
NIH Public Access  
• Recipients of ICTS funding are required to cite the ICTS award in peer-
reviewed publications that result from ICTS funding.  This session will 
provide an overview of the NIH Public Access Policy including the steps 
involved in complying with the policy and how to demonstrate 
compliance.  
 
Optimizing Dissemination of Research  
• Optimizing discoverability and access of research findings is the surest 
way to enhance visibility and impact of ICTS research efforts. This 
session will review a variety of strategies for investigators and scholars 
to consider as they prepare to disseminate their research.   
  
Reporting Impact  
• The ability to effectively demonstrate Return on Investment (ROI) and 
impact is essential for ICTS reporting purposes and can also be a very 
valuable component of promotion and tenure activities. This session 
will describe how investigators and scholars can effectively report on 
impact and “success stories” from ICTS funding using publication data, 
grant application/award data, new or promising discoveries, 
collaborations, and other information.    
 
Translating this into your own 
environment… 
Translating this into your own environment 
Partnerships for Environmental Public Health 
(PEPH) Evaluation Metrics Manual 
Sample metrics from grantee programs include: 
• Demonstrating success at identifying partners — The 
University of Cincinnati’s anti-idling campaign provided a 
description of the partners involved and the resources they 
bring to the project. Cincinnati Public Schools (CPS) 
provided access to students and schools, Cincinnati Health 
Department provided nursing services, a Councilwoman 
provided credibility and the ability to attract attention to 
the project, and the Hamilton County Department of 
Environmental Services provided training and information 
to CPS staff and students. 
• Demonstrating that they communicated their findings 
in a variety of products — The Bay Area Breast Cancer 
and the Environment Research Center described the 
number and demographics of their social media audience. 
The center has more than 1,000 followers on twitter and 
864 Facebook friends. Followers are 70 percent female and 
more than half are age 40 or older. 
• Demonstrating the policy impacts of their advocacy — 
The Trade, Health, and Environment Impact Project at the 
University of Southern California documented its 
contribution to the formation of the San Pedro Bay Ports 
Clean Air Action Plan. The plan stated that the Ports of Los 
Angeles and Long Beach would reduce air pollution by 45 
percent by 2011. The project also documented its 
involvement in passing the Clean Air Action Plan, which 
established a progressive ban on polluting trucks. The plan 
resulted in a 70 percent reduction in port truck emissions 
in the Port of Los Angeles in the first year. 
• NIEHS Division of Extramural Research and 
Training 
• Ideas about how to measure and document 
success 
More information about the manual & developing metrics at www.niehs.nih.gov/pephmetrics 
Questions? 
Supporting Dissemination & Impact 
Jae Allen, MBA 
Strategies and people. 
T&E Team Role 
• Strategy: Develop, describe & implement T&E 
aims and procedures to measure impact of 
the WU CTSA 
• Data: Collect, clean and store information 
– Data elements (ex. publications, grants received) 
– Examples of successful research (vignettes) 
• Analysis: Apply our diverse areas of expertise 
to analyze information and develop 
representations (graphs, tables, charts) 
 
T&E Team Role, continued 
• Illustrate: Weave the various representations 
into a description of impact 
• Disseminate our findings through multiple 
communication channels 
 
Weaving the Tapestry of Impact 
Describing Impact, to date: 
• Built infrastructure to support clinical & 
translational research (Elizabeth) 
• Broke down barriers to increase research 
collaborations (Cathy & Bobbi) 
• Measured quality and extent of clinical & 
translational science (Cathy) 
 
How do we take the next step of describing IMPACT? 
New Initiatives 
• New Resources 
– Navigation Resources (Betsy Keath, PhD) 
– Research Forums (John Kotyk, PhD) 
• Return on Investment for Funding Programs 
• Becker Model Implementation 
New Resources 
• Personalized Consultation (Dr. Keath) 
– Research and Teaching Experience 
• Experience as lead investigator, educator and mentor in University 
setting (20+ yrs) 
• Participated in scientific review on national study sections (6 yrs) 
– Scientific Programme Officer for Science Foundation Ireland 
– Consultant for Irish Cancer Society 
• Needs assessment 
• Gap analysis on priority topics to influence agency policy 
 
• eNavigator Portal 
http://www.icts.wustl.edu/icts-researchers/icts-cores/contact-icts-navigator 
New Resources, cont. 
• Research Forum – Child Health (Dr. Kotyk) 
– Pharmaceutical Industry, Research Fellow (17 years) 
• Research – drug discovery and development 
• Project management 
– Research Associate Professor of Radiology (8 years) 
• Helped create the WU Center for Clinical Imaging Research 
• Established the ICTS Human Imaging Unit 
• Protocol/Project development 
 
• Personal connections to the success stories 
Annual ROI Analysis 
• Annual Clinical & Translational Awards 
– ~20 awards, ~ $50,000 
• Progress Reports & Annual Surveys (5 yrs post) 
– External Grants Submitted 
– External Grants Awarded 
– Publications 
 
Pilot Program ROI 
# Years Post Award External Funding, in Millions # External Grants 
1 $10.2 10 
2 $27.7 25 
3 $46.7 40 
4 $47.2 41 
Return of $5.51 per dollar spent on the program over 5 years. 
Dissemination &  
Communication Channels 
ICTS Website: Audiences 
 
 
ICTS Website: Impact Section 
 
 
WU Public Affairs (Outlook Magazine) 
Outlook Magazine 
Dissemination: Communication Channels 
• Monthly “ICTS Digest”: email with links to 
website updates 
• Emails to Members 
• Scholarly works (posters and publications) 
• Annual Progress Reports 
 
Benefit at Multiple Levels 
• Individual: highlights accomplishments and 
documents career progression 
• ICTS: illustrates value & informs decision making 
• Institution: enhances intra-institutional 
connections, strategic value for Washington 
University 
• Consortium: illustrates value and impact of 
national community health research, inter-
institutional with local partners 
How do YOU illustrate Impact? 
Sharing roundtable discussion. 
Open Discussion  
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